Guanfacine (Intuniv) is an alpha 2A agonist indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents for whom stimulants are not appropriate. This article discusses the indications, monitoring requirements and clinical trial results. Copyright © 2016 Wiley Interface Ltd
CITATION STYLE
Chaplin, S. (2016). Guanfacine to control ADHD in children and adolescents. Prescriber, 27(7), 37–38. https://doi.org/10.1002/psb.1481
Mendeley helps you to discover research relevant for your work.